Company details

HEADCOUNT

25-99

ORG TYPE

Corporate

SECTOR

Technology & Digital

WEBSITE

http://www.genome.eu/

About the company

Genome is a Vilnius-based fintech offering personal, business, and merchant accounts with online onboarding, multi-currency balances, and money transfers (including SEPA and SWIFT). Genome operates as an Electronic Money Institution under the legal entity UAB “Maneuver LT” and positions the service as a “banking alternative” that is faster and fully online. The company also markets card products and merchant payment features, alongside a focus on security and compliance. Public company profiles place Genome in a small-to-mid size band rather than a large enterprise.

Locations and presence

Genome is based in Vilnius, Lithuania, and frames many roles as office-based in Vilnius. Some engineering roles are advertised as remote within Europe.

Palpable Score

51.4

/ 100

Genome is a workable early-career option in support and compliance, mainly because several roles accept 1–2 years of experience and the company publishes salary ranges for multiple positions. The score is capped by a lack of visible true “0 years” roles, plus thin public evidence on progression and retention outcomes.

Pillar 1: Early-career access

Score

8.0

/ 20

The company advertises several near-entry roles like Customer Support Manager and KYC and Customer Due Diligence Specialist that ask for around 1 year of relevant experience rather than 3–5+.
Genome’s current openings list skews senior overall, including roles like Senior Java Developer (5+ years) and leadership hires such as Head of Customer Support and Chief Commercial Officer.
The company does not show internships, graduate schemes, or “no experience required” roles on the careers page, so first-job access is limited.

Pillar 2: Hiring fairness and transparency

Score

12.0

/ 20

The company’s careers page includes applicant data-handling notes, consent language, and a DPO contact, which is a solid baseline for candidate rights.
Genome applications run through a simple web form or email submission, but the company does not publish interview stages, expected timelines, or what assessments look like.
The company publishes salary ranges and benefit lists on multiple job descriptions, which helps candidates self-screen before applying.

Pillar 3: Learning and support

Score

10.8

/ 20

The company’s compliance job descriptions include explicit “mandatory and self-directed learning” expectations and mention supporting the training of new specialists when required.
Genome lists funded development-adjacent benefits such as partial reimbursement for English courses and paid participation in professional events.
The company does not describe onboarding structure, mentoring, buddy systems, or review cadence in public role descriptions, which makes support hard to verify for true juniors.

Pillar 4: Pay fairness and stability

Score

12.8

/ 20

The company publishes gross monthly salary ranges for multiple roles, including Customer Support Manager (€1,635–€1,919) and KYC/CDD Specialist (€2,400–€2,800).
Genome includes concrete stability benefits across roles such as corporate medical insurance and partial reimbursement for language and sport subscriptions.
The company does not publish pay ranges for every function (for example, some engineering roles list benefits but not compensation), so transparency is partial rather than consistent.

Pillar 5: Early-career outcomes

Score

7.8

/ 20

The company has very limited employee-review volume for the Lithuania employer profile, with one recent review describing a professional, friendly environment and well-defined responsibilities, which is encouraging but not enough to generalise.
Genome’s professional networking profile places the team in a 51–200 employee size band, which suggests the company is beyond the “tiny startup” stage, but it does not confirm junior promotion patterns.
The company does not publish early-career outcomes like promotion timelines, retention metrics, or junior success stories, so outcomes evidence remains thin.